SEC Form 4 · accession 0001209191-18-049208
Karyopharm Therapeutics Inc. · KPTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carsten Thiel
Director
Period of report
Aug 31, 2018
Accepted (ET)
Sep 4, 2018 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonstatutory stock option (right to buy)F1 | $21.05 | Aug 31, 2018 | A | 34,000 | A | — | Aug 30, 2028 | Common Stock | 34,000 | 34,000 | D |
Explanation of responses
- F1This option was granted on August 31, 2018. The shares underlying this option vest as to one-third (1/3) of the shares on August 31, 2019 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter.